{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:56:28Z","timestamp":1790762188764,"version":"4.1.0"},"reference-count":250,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["1175134"],"award-info":[{"award-number":["1175134"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Rainbow Foundation"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["1079187"],"award-info":[{"award-number":["1079187"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000774","name":"University of Newcastle","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001249","name":"University of Tasmania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001249","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10787-020-00770-y","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T11:05:07Z","timestamp":1604574307000},"page":"15-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators"],"prefix":"10.1007","volume":"29","author":[{"given":"Madhur D.","family":"Shastri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Chin","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik Q.","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtaza","family":"Tambuwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh K.","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole G.","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakti D.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4741-3035","authenticated-orcid":false,"given":"Philip M.","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"770_CR1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.129.2.266","volume":"129","author":"AM Abdel-Rahman","year":"2006","unstructured":"Abdel-Rahman AM, El-Sahrigy SA, Bakr SI (2006) A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest 129:266\u2013271","journal-title":"Chest"},{"key":"770_CR2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11882-008-0028-4","volume":"8","author":"IM Adcock","year":"2008","unstructured":"Adcock IM, Ford PA, Bhavsar P, Ahmad T, Chung KF (2008) Steroid resistance in asthma: mechanisms and treatment options. Curr Allergy Asthma Rep 8:171","journal-title":"Curr Allergy Asthma Rep"},{"key":"770_CR3","unstructured":"Adhikari K, Buatong W, Thawithong E, Suwandecha T, Srichana T (2015) Factors affecting enhanced permeation of amphotericin B across cell membranes and safety of formulation. AAPS Pharm-SciTech 17(4):820\u2013828"},{"key":"770_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1152\/jappl.1982.53.1.175","volume":"53","author":"T Ahmed","year":"1982","unstructured":"Ahmed T, Mirbahar KB, Oliver W Jr, Eyre P, Wanner A (1982) Characterization of H1-and H2-receptor function in pulmonary and systemic circulations of sheep. J Appl Physiol 53:175\u2013184","journal-title":"J Appl Physiol"},{"key":"770_CR5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cmmi.1678","volume":"11","author":"A Al Faraj","year":"2016","unstructured":"Al Faraj A, Shaik AS, Afzal S, Al-Muhsen S, Halwani R (2016) Specific targeting and noninvasive magnetic resonance imaging of an asthma biomarker in the lung using polyethylene glycol functionalized magnetic nanocarriers. Contrast Media Mol Imaging 11:172\u2013183","journal-title":"Contrast Media Mol Imaging"},{"key":"770_CR6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2222.2003.01576.x","volume":"33","author":"K Asai","year":"2003","unstructured":"Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J (2003) Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 33:595\u2013599","journal-title":"Clin Exp Allergy"},{"key":"770_CR7","unstructured":"Asher MI, Ellwood P (2014) The global asthma report 2014. Global Asthma Network. 2020"},{"key":"770_CR8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(06)69283-0","volume":"368","author":"MI Asher","year":"2006","unstructured":"Asher MI et al (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368:733\u2013743","journal-title":"Lancet"},{"key":"770_CR9","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2174\/1568026616666150930121157","volume":"16","author":"P Bakakos","year":"2016","unstructured":"Bakakos P, Patentalakis G, Papi A (2016) Vascular biomarkers in asthma and COPD. Curr Top Med Chem 16:1599\u20131609","journal-title":"Curr Top Med Chem"},{"key":"770_CR10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0002-9440(10)63369-X","volume":"165","author":"P Baluk","year":"2004","unstructured":"Baluk P, Lee CG, Link H, Ator E, Haskell A, Elias JA, McDonald DM (2004) Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am J Pathol 165:1071\u20131085","journal-title":"Am J Pathol"},{"key":"770_CR11","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1021\/acs.molpharmaceut.6b00360","volume":"13","author":"H Bandara","year":"2016","unstructured":"Bandara H, Herpin M, Kolacny D Jr, Harb A, Romanovicz D, Smyth H (2016) Incorporation of farnesol significantly increases the efficacy of liposomal ciprofloxacin against Pseudomonas aeruginosa biofilms in vitro. Mol Pharm 13:2760\u20132770","journal-title":"Mol Pharm"},{"key":"770_CR12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/rr39","volume":"2","author":"PJ Barnes","year":"2001","unstructured":"Barnes PJ (2001) Th2 cytokines and asthma: an introduction. Respir Res 2:64\u201365","journal-title":"Respir Res"},{"key":"770_CR13","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.1038\/sj.bjp.0706437","volume":"147","author":"PJ Barnes","year":"2006","unstructured":"Barnes PJ (2006) Drugs for asthma. Br J Pharmacol 147:S297-303. https:\/\/doi.org\/10.1038\/sj.bjp.0706437","journal-title":"Br J Pharmacol"},{"key":"770_CR14","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1172\/JCI36130","volume":"118","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ (2008) The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 118:3546\u20133556","journal-title":"J Clin Invest"},{"key":"770_CR15","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","volume":"373","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ, Adcock IM (2009) Glucocorticoid resistance in inflammatory diseases. The Lancet 373:1905\u20131917","journal-title":"The Lancet"},{"key":"770_CR16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1081-1206(10)61065-4","volume":"96","author":"ED Bateman","year":"2006","unstructured":"Bateman ED et al (2006) Efficacy and safety of roflumilast in the treatment of asthma. Ann Allergy, Asthma Immunol 96:679\u2013686","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"770_CR17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(97)07302-9","volume":"351","author":"R Beasley","year":"1998","unstructured":"Beasley R (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351:1225\u20131232","journal-title":"Lancet"},{"key":"770_CR18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/14712598.2019.1579794","volume":"19","author":"KM Beck","year":"2019","unstructured":"Beck KM, Koo J (2019) Brodalumab for the treatment of plaque psoriasis: up-to-date. Expert Opin Biol Ther 19:287\u2013292","journal-title":"Expert Opin Biol Ther"},{"key":"770_CR19","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1164\/rccm.200209-1030OC","volume":"167","author":"L Benayoun","year":"2003","unstructured":"Benayoun L, Druilhe A, Dombret M-C, Aubier M, Pretolani M (2003) Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 167:1360\u20131368","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.164.4.2011040","volume":"164","author":"PN Black","year":"2001","unstructured":"Black PN et al (2001) Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 164:536\u2013541","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/art.40070","volume":"69","author":"FJ Blanco","year":"2017","unstructured":"Blanco FJ et al (2017) Secukinumab in active rheumatoid arthritis: a phase III randomized, double-blind, active comparator\u2013and placebo-controlled study. Arthritis & rheumatology 69:1144\u20131153","journal-title":"Arthritis & rheumatology"},{"key":"770_CR22","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","volume":"388","author":"ER Bleecker","year":"2016","unstructured":"Bleecker ER et al (2016) Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet 388:2115\u20132127","journal-title":"Lancet"},{"key":"770_CR23","doi-asserted-by":"crossref","first-page":"e0163539","DOI":"10.1371\/journal.pone.0163539","volume":"11","author":"RA Blom","year":"2016","unstructured":"Blom RA et al (2016) A Triple Co-Culture Model of the Human Respiratory Tract to Study Immune-Modulatory Effects of Liposomes and Virosomes. PLoS ONE 11:e0163539","journal-title":"PLoS ONE"},{"key":"770_CR24","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1164\/ajrccm.160.6.9808146","volume":"160","author":"LC Borish","year":"1999","unstructured":"Borish LC, Nelson HS, Lanz MJ, Claussen L, Whitmore JB, Agosti JM, Garrison L (1999) Interleukin-4 receptor in moderate atopic asthma: a phase I\/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 160:1816\u20131823","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1067\/mai.2001.115624","volume":"107","author":"LC Borish","year":"2001","unstructured":"Borish LC, Nelson HS, Corren J, Bensch G, Busse WW, Whitmore JB, Agosti JM (2001) Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 107:963\u2013970","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1398-9995.2005.00931.x","volume":"61","author":"J Bousquet","year":"2006","unstructured":"Bousquet J et al (2006) Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma. Allergy 61:72\u201378","journal-title":"Allergy"},{"key":"770_CR27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nm.3300","volume":"19","author":"GG Brusselle","year":"2013","unstructured":"Brusselle GG, Maes T, Bracke KR (2013) Eosinophils in the spotlight: eosinophilic airway inflammation in nonallergic asthma. Nat Med 19:977\u2013979","journal-title":"Nat Med"},{"key":"770_CR28","first-page":"280","volume":"297","author":"DS Bundschuh","year":"2001","unstructured":"Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R (2001) In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J Pharmacol Exp Ther 297:280\u2013290","journal-title":"J Pharmacol Exp Ther"},{"key":"770_CR29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1164\/rccm.200904-0631OC","volume":"181","author":"JK Burgess","year":"2010","unstructured":"Burgess JK et al (2010) Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness. Am J Respir Crit Care Med 181:106\u2013115","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR30","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","volume":"188","author":"WW Busse","year":"2013","unstructured":"Busse WW, Holgate S, Kerwin E, Chon Y, Feng J, Lin J, Lin S-L (2013) Randomized, double-blind, placebo-controlled study of brodalumab, a human anti\u2013IL-17 receptor monoclonal antibody, in moderate to severe asthma. Am J Respir Crit Care Med 188:1294\u20131302","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR31","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1613125","volume":"376","author":"KN Cahill","year":"2017","unstructured":"Cahill KN et al (2017) KIT inhibition by imatinib in patients with severe refractory asthma. N Engl J Med 376:1911\u20131920","journal-title":"N Engl J Med"},{"key":"770_CR32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","volume":"374","author":"PM Calverley","year":"2009","unstructured":"Calverley PM, Rabe KF, Goehring U-M, Kristiansen S, Fabbri LM, Martinez FJ (2009) Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. The Lancet 374:685\u2013694","journal-title":"The Lancet"},{"key":"770_CR33","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fimmu.2017.01835","volume":"8","author":"LdN Camargo","year":"2018","unstructured":"Camargo LdN et al (2018) Effects of anti-IL-17 on inflammation, remodeling, and oxidative stress in an experimental model of asthma exacerbated by LPS. Frontiers in immunology 8:1835","journal-title":"Frontiers in immunology"},{"key":"770_CR34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","volume":"6","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389\u2013396","journal-title":"Nat Med"},{"key":"770_CR35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932\u2013936","journal-title":"Nature"},{"key":"770_CR36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpb.2016.11.026","volume":"118","author":"A Castoldi","year":"2016","unstructured":"Castoldi A et al (2016) Calcifediol-loaded liposomes for local treatment of pulmonary bacterial infections. Eur J Pharm Biopharm 118:62\u201367","journal-title":"Eur J Pharm Biopharm"},{"key":"770_CR1000","doi-asserted-by":"crossref","unstructured":"Castro M, Wenzel SE, Bleecker ER, Pizzichini E, Kuna P, Busse WW, Gossage DL, Ward CK, Wu Y, Wang B (2014) Benralizumab, an anti-interleukin 5 receptor \u03b1 monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study. The Lancet Respir Med 2:879\u2013890","DOI":"10.1016\/S2213-2600(14)70201-2"},{"key":"770_CR37","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M et al (2018) Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378:2486\u20132296","journal-title":"N Engl J Med"},{"key":"770_CR38","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1067\/mai.2003.1557","volume":"111","author":"J Chakir","year":"2003","unstructured":"Chakir J et al (2003) Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-\u03b2, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 111:1293\u20131298","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR39","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1096\/fj.12-208033","volume":"26","author":"Y Chang","year":"2012","unstructured":"Chang Y et al (2012) Th17-associated cytokines promote human airway smooth muscle cell proliferation. FASEB J 26:5152\u20135160","journal-title":"FASEB J"},{"key":"770_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pupt.2017.01.001","volume":"42","author":"M Chen","year":"2017","unstructured":"Chen M et al (2017) MiR-23b controls TGF-beta1 induced airway smooth muscle cell proliferation via direct targeting of Smad3. Pulm Pharmacol Ther 42:33\u201342. https:\/\/doi.org\/10.1016\/j.pupt.2017.01.001","journal-title":"Pulm Pharmacol Ther"},{"key":"770_CR41","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1164\/rccm.201405-0859PP","volume":"190","author":"J Chesn\u00e9","year":"2014","unstructured":"Chesn\u00e9 J, Braza F, Mahay G, Brouard S, Aronica M, Magnan A (2014) IL-17 in severe asthma. Where do we stand? Am J Respir Crit Care Med 190:1094\u20131101","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR42","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.200207-710OC","volume":"167","author":"A Chetta","year":"2003","unstructured":"Chetta A et al (2003) Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am J Respir Crit Care Med 167:751\u2013757","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR43","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-cellbio-092910-154002","volume":"27","author":"AS Chung","year":"2011","unstructured":"Chung AS, Ferrara N (2011) Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27:563\u2013584","journal-title":"Annu Rev Cell Dev Biol"},{"key":"770_CR44","unstructured":"ClinicalTrial (2015) Safety, tolerability, and efficacy of AIN457 in patients with uncontrolled asthma (NCT01478360). US National Library of Medicine,"},{"key":"770_CR45","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","volume":"377","author":"J Corren","year":"2017","unstructured":"Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, van der Merwe R (2017) Tezepelumab in adults with uncontrolled asthma. N Engl J Med 377:936\u2013946","journal-title":"N Engl J Med"},{"key":"770_CR46","doi-asserted-by":"crossref","first-page":"AB80","DOI":"10.1016\/j.jaci.2017.12.259","volume":"141","author":"J Corren","year":"2018","unstructured":"Corren J et al (2018) Tezepelumab demonstrates clinically meaningful improvements in asthma control (ACQ-6) in patients with uncontrolled asthma: results from a phase 2b clinical trial. J Allergy Clin Immunol 141:AB80","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.183.1.109","volume":"183","author":"DB Corry","year":"1996","unstructured":"Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM (1996) Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 183:109\u2013117","journal-title":"J Exp Med"},{"key":"770_CR48","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1172\/JCI101765","volume":"25","author":"JJ Curry","year":"1946","unstructured":"Curry JJ (1946) The effect of antihistamine substances and other drugs on histamine bronchoconstriction in asthmatic subjects. J Clin Investig 25:792\u2013799","journal-title":"J Clin Investig"},{"key":"770_CR700","unstructured":"D\u2019Amato G, Salzillo A, Piccolo A, D\u2019Amato M, Liccardi G (2007) A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma. Ther Clin Risk Manage 3:613"},{"key":"770_CR49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pupt.2015.07.003","volume":"34","author":"S Di Gioia","year":"2015","unstructured":"Di Gioia S et al (2015) Nanocomplexes for gene therapy of respiratory diseases: targeting and overcoming the mucus barrier. Pulm Pharmacol Ther 34:8\u201324","journal-title":"Pulm Pharmacol Ther"},{"key":"770_CR50","doi-asserted-by":"crossref","first-page":"S539","DOI":"10.1067\/mai.2002.124568","volume":"109","author":"R Djukanovic","year":"2002","unstructured":"Djukanovic R (2002) Airway inflammation in asthma and its consequences: implications for treatment in children and adults. J Allergy Clin Immunol 109:S539\u2013S548","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR51","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1172\/JCI741","volume":"101","author":"C Doucet","year":"1998","unstructured":"Doucet C, Brouty-Boy\u00e9 D, Pottin-Cl\u00e9menceau C, Canonica GW, Jasmin C, Azzarone B (1998) Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Investig 101:2129\u20132139","journal-title":"J Clin Investig"},{"key":"770_CR52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/thorax.57.7.643","volume":"57","author":"J Douwes","year":"2002","unstructured":"Douwes J, Gibson P, Pekkanen J, Pearce N (2002) Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57:643\u2013648","journal-title":"Thorax"},{"key":"770_CR53","first-page":"243","volume":"5","author":"K Dua","year":"2017","unstructured":"Dua K et al (2017a) Chitosan and its derivatives in nanocarrier based pulmonary drug delivery systems. Pharm Nanotechnol 5:243\u2013249","journal-title":"Pharm Nanotechnol"},{"key":"770_CR54","doi-asserted-by":"crossref","unstructured":"Dua K, Hansbro NG, Foster PS, Hansbro PM (2017b) MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases. Drug Deliv Transl Res 7(1):168\u2013178","DOI":"10.1007\/s13346-016-0343-6"},{"key":"770_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.molimm.2015.12.015","volume":"71","author":"RM Elbehidy","year":"2016","unstructured":"Elbehidy RM, Youssef DM, El-Shal AS, Shalaby SM, Sherbiny HS, Sherief LM, Akeel NE (2016) MicroRNA-21 as a novel biomarker in diagnosis and response to therapy in asthmatic children. Mol Immunol 71:107\u2013114. https:\/\/doi.org\/10.1016\/j.molimm.2015.12.015","journal-title":"Mol Immunol"},{"key":"770_CR56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11882-003-0029-2","volume":"3","author":"M Ennis","year":"2003","unstructured":"Ennis M (2003) Neutrophils in asthma pathophysiology. Curr Allergy Asthma Rep 3:159\u2013165","journal-title":"Curr Allergy Asthma Rep"},{"key":"770_CR57","unstructured":"Esposito S, Blasi F, Bosis F (2004) Efficacy of clarithromycin for the treatment of acute episodes of bronchospasm in children with a history of recurrent wheezing. In: 22nd annual meeting of European Society for Pediatric Infectious Diseases (ESPID). Tampere, Finland, 2004"},{"key":"770_CR58","doi-asserted-by":"crossref","first-page":"e1002244","DOI":"10.1371\/journal.ppat.1002244","volume":"7","author":"A-T Essilfie","year":"2011","unstructured":"Essilfie A-T et al (2011) Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog 7:e1002244","journal-title":"PLoS Pathog"},{"key":"770_CR59","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/thoraxjnl-2011-200160","volume":"67","author":"AT Essilfie","year":"2012","unstructured":"Essilfie AT et al (2012) Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 67:588\u2013599. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200160","journal-title":"Thorax"},{"key":"770_CR60","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/thoraxjnl-2014-206067","volume":"70","author":"A-T Essilfie","year":"2015","unstructured":"Essilfie A-T et al (2015) Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. Thorax 70:458\u2013467. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206067","journal-title":"Thorax"},{"key":"770_CR61","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/JAA.S153097","volume":"11","author":"I Esteban-Gorgojo","year":"2018","unstructured":"Esteban-Gorgojo I, Antol\u00edn-Am\u00e9rigo D, Dom\u00ednguez-Ortega J, Quirce S (2018) Non-eosinophilic asthma: current perspectives. J Asthma Allergy 11:267\u2013281. https:\/\/doi.org\/10.2147\/JAA.S153097","journal-title":"J Asthma Allergy"},{"key":"770_CR62","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/01902148.2016.1256452","volume":"42","author":"L Fan","year":"2016","unstructured":"Fan L et al (2016) MicroRNA-145 influences the balance of Th1\/Th2 via regulating RUNX3 in asthma patients. Exp Lung Res 42:417\u2013424. https:\/\/doi.org\/10.1080\/01902148.2016.1256452","journal-title":"Exp Lung Res"},{"key":"770_CR63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JAA.S157762","volume":"11","author":"GT Ferguson","year":"2018","unstructured":"Ferguson GT et al (2018) Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma. J Asthma Allergy 11:63\u201372","journal-title":"J Asthma Allergy"},{"key":"770_CR64","unstructured":"Ferrara N (2007) Vascular endothelial growth factor: pathophysiology and clinical implications. In: Angiogenesis From basic science to clinical applications, pp 1\u201336"},{"key":"770_CR65","unstructured":"Fireman P (2003) Understanding asthma pathophysiology. In: Allergy and asthma proceedings, 2003. vol 2. OceanSide Publications, Inc, pp 79\u201383"},{"key":"770_CR66","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.4049\/jimmunol.1301360","volume":"191","author":"LK Fogli","year":"2013","unstructured":"Fogli LK et al (2013) T cell\u2013derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia. J Immunol 191:3100\u20133111","journal-title":"J Immunol"},{"key":"770_CR67","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/imr.12058","volume":"253","author":"PS Foster","year":"2013","unstructured":"Foster PS et al (2013) The emerging role of microRNAs in regulating immune and inflammatory responses in the lung. Immunol Rev 253:198\u2013215","journal-title":"Immunol Rev"},{"key":"770_CR68","unstructured":"Frieri M (2005) Asthma concepts in the new millennium: update in asthma pathophysiology. In: Allergy and asthma proceedings, 2005. vol 2. OceanSide Publications, Inc, pp 83\u201388"},{"key":"770_CR69","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1056\/NEJMe1702653","volume":"376","author":"SJ Galli","year":"2017","unstructured":"Galli SJ (2017) Mast Cells and KIT as Potential Therapeutic Targets in Severe Asthma. N Engl J Med 376:1983\u20131984","journal-title":"N Engl J Med"},{"key":"770_CR70","first-page":"1","volume":"7","author":"I Galv\u00e3o","year":"2020","unstructured":"Galv\u00e3o I, Kim RY, Shen S, Budden KF, Vieira AT, Hansbro PM (2020) Emerging therapeutic targets and preclinical models for severe asthma. Expert Opin Ther Targets 7:1\u201313","journal-title":"Expert Opin Ther Targets"},{"key":"770_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3743048","author":"H Gao","year":"2017","unstructured":"Gao H, Ying S, Dai Y (2017) Pathological roles of neutrophil-mediated inflammation in asthma and its potential for therapy as a target. J Immunol Res. https:\/\/doi.org\/10.1155\/2017\/3743048","journal-title":"J Immunol Res"},{"key":"770_CR72","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/all.13041","volume":"72","author":"M Garbani","year":"2016","unstructured":"Garbani M et al (2016) Allergen-loaded strontium-doped hydroxyapatite spheres improve allergen-specific immunotherapy in mice. Allergy 72:570\u2013578","journal-title":"Allergy"},{"key":"770_CR73","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1165\/ajrcmb.20.2.3327","volume":"20","author":"CG Garlisi","year":"1999","unstructured":"Garlisi CG et al (1999) Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol 20:248\u2013255","journal-title":"Am J Respir Cell Mol Biol"},{"key":"770_CR74","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","volume":"370","author":"GM Gauvreau","year":"2014","unstructured":"Gauvreau GM et al (2014) Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 370:2102\u20132110","journal-title":"N Engl J Med"},{"key":"770_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-017-0146-y","volume":"7","author":"J Genuneit","year":"2017","unstructured":"Genuneit J et al (2017) The state of asthma epidemiology: an overview of systematic reviews and their quality. Clin Transl Allergy 7:1\u20139","journal-title":"Clin Transl Allergy"},{"key":"770_CR76","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","volume":"390","author":"PG Gibson","year":"2017","unstructured":"Gibson PG et al (2017) Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet 390:659\u2013668","journal-title":"Lancet"},{"key":"770_CR77","doi-asserted-by":"crossref","first-page":"e85655","DOI":"10.1371\/journal.pone.0085655","volume":"9","author":"KT Grafton","year":"2014","unstructured":"Grafton KT, Moir LM, Black JL, Hansbro NG, Hansbro PM, Burgess JK, Oliver BG (2014) LF-15 & T7, synthetic peptides derived from tumstatin, attenuate aspects of airway remodelling in a murine model of chronic OVA-induced allergic airway disease. PLoS ONE 9:e85655","journal-title":"PLoS ONE"},{"key":"770_CR78","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/thorax.57.10.875","volume":"57","author":"RH Green","year":"2002","unstructured":"Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID (2002) Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57:875\u2013879","journal-title":"Thorax"},{"key":"770_CR79","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/MCP.0b013e32835a5bc8","volume":"19","author":"CM Greene","year":"2013","unstructured":"Greene CM, Gaughan KP (2013) microRNAs in asthma: potential therapeutic targets. Curr Opin Pulm Med 19:66\u201372","journal-title":"Curr Opin Pulm Med"},{"key":"770_CR80","first-page":"485","volume":"53","author":"A Grigoras","year":"2012","unstructured":"Grigoras A, Caruntu I-D, Grigoras C, Mihaescu T, Amalinei C (2012) Relationship between immunohistochemical assessment of bronchial mucosa microvascularization and clinical stage in asthma. Rom J Morphol Embryol 53:485\u2013490","journal-title":"Rom J Morphol Embryol"},{"key":"770_CR81","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1126\/science.282.5397.2261","volume":"282","author":"G Gr\u00fcnig","year":"1998","unstructured":"Gr\u00fcnig G et al (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261\u20132263","journal-title":"Science"},{"key":"770_CR82","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/all.12551","volume":"70","author":"I Haj-Salem","year":"2015","unstructured":"Haj-Salem I et al (2015) MicroRNA-19a enhances proliferation of bronchial epithelial cells by targeting TGFbetaR2 gene in severe asthma. Allergy 70:212\u2013219. https:\/\/doi.org\/10.1111\/all.12551","journal-title":"Allergy"},{"key":"770_CR83","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","volume":"360","author":"P Haldar","year":"2009","unstructured":"Haldar P et al (2009) Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 360:973\u2013984","journal-title":"N Engl J Med"},{"key":"770_CR84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2013.12.003","volume":"151","author":"TS Hallstrand","year":"2014","unstructured":"Hallstrand TS, Hackett TL, Altemeier WA, Matute-Bello G, Hansbro PM, Knight DA (2014) Airway epithelial regulation of pulmonary immune homeostasis and inflammation. Clin Immunol 151:1\u201315","journal-title":"Clin Immunol"},{"key":"770_CR85","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1038\/emm.2016.89","volume":"48","author":"R Halwani","year":"2016","unstructured":"Halwani R, Shaik AS, Ratemi E, Afzal S, Kenana R, Al-Muhsen S, Al Faraj A (2016) A novel anti-IL4R\u03b1 nanoparticle efficiently controls lung inflammation during asthma. Exp Mol Med 48:e262","journal-title":"Exp Mol Med"},{"key":"770_CR86","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-2600(16)30265-X","volume":"4","author":"NA Hanania","year":"2016","unstructured":"Hanania NA et al (2016) Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 4:781\u2013796","journal-title":"Lancet Respir Med"},{"key":"770_CR87","doi-asserted-by":"crossref","first-page":"AB15","DOI":"10.1016\/j.jaci.2017.12.048","volume":"141","author":"NA Hanania","year":"2018","unstructured":"Hanania NA, Ros\u00e9n K, Griffin NM, Trzaskoma BL, Haselkorn T, Chipps BE, Casale TB (2018) Response to omalizumab observed over wide range of blood eosinophil levels. J Allergy Clin Immunol 141:AB15","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1476-5381.2011.01219.x","volume":"163","author":"PM Hansbro","year":"2011","unstructured":"Hansbro PM, Kaiko GE, Foster PS (2011) Cytokine\/anti-cytokine therapy\u2013novel treatments for asthma? Br J Pharmacol 163:81\u201395","journal-title":"Br J Pharmacol"},{"key":"770_CR89","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/13543784.2013.732997","volume":"22","author":"PM Hansbro","year":"2013","unstructured":"Hansbro PM et al (2013) Th2 cytokine antagonists: potential treatments for severe asthma. Expert Opin Investig Drugs 22:49\u201369","journal-title":"Expert Opin Investig Drugs"},{"key":"770_CR90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12543","volume":"278","author":"PM Hansbro","year":"2017","unstructured":"Hansbro PM et al (2017) Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma. Immunol Rev 278:41\u201362","journal-title":"Immunol Rev"},{"key":"770_CR91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pharmthera.2014.11.010","volume":"148","author":"LM Harkness","year":"2015","unstructured":"Harkness LM, Ashton AW, Burgess JK (2015) Asthma is not only an airway disease, but also a vascular disease. Pharmacol Ther 148:17\u201333","journal-title":"Pharmacol Ther"},{"key":"770_CR800","doi-asserted-by":"crossref","unstructured":"Hart T, Blackburn M, Brigham\u2010Burke M, Dede K, Al\u2010Mahdi N, Zia\u2010Amirhosseini P, Cook R (2002) Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti\u2010interleukin\u20104 antibody with therapeutic potential in asthma. Clin Exp Immunol 130:93\u2013100","DOI":"10.1046\/j.1365-2249.2002.01973.x"},{"key":"770_CR92","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1378\/chest.127.3.965","volume":"127","author":"M Hashimoto","year":"2005","unstructured":"Hashimoto M, Tanaka H, Abe S (2005) Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 127:965\u2013972","journal-title":"Chest"},{"key":"770_CR93","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1083\/jcb.153.3.543","volume":"153","author":"M Hellstr\u00f6m","year":"2001","unstructured":"Hellstr\u00f6m M, Gerhardt H, Kal\u00e9n M, Li X, Eriksson U, Wolburg H, Betsholtz C (2001) Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153:543\u2013554","journal-title":"J Cell Biol"},{"key":"770_CR900","doi-asserted-by":"crossref","unstructured":"Hendeles L, Asmus M, Chesrown S (2004) Evaluation of cytokine modulators for asthma. Paediatr Respir Rev 5:S107\u2013S112","DOI":"10.1016\/S1526-0542(04)90020-6"},{"key":"770_CR94","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.4049\/jimmunol.164.2.1086","volume":"164","author":"WR Henderson","year":"2000","unstructured":"Henderson WR, Chi EY, Maliszewski CR (2000) Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J Immunol 164:1086\u20131095","journal-title":"J Immunol"},{"key":"770_CR95","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/resp.12606","volume":"20","author":"C Herbert","year":"2015","unstructured":"Herbert C, Sebesfi M, Zeng QX, Oliver BG, Foster PS, Kumar RK (2015) Using multiple online databases to help identify microRNAs regulating the airway epithelial cell response to a virus-like stimulus. Respirology 20:1206\u20131212","journal-title":"Respirology"},{"key":"770_CR96","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1021\/acs.jafc.5b04861","volume":"64","author":"CY Ho","year":"2016","unstructured":"Ho CY, Lu CC, Weng CJ, Yen GC (2016) Protective effects of diallyl sulfide on ovalbumin-induced pulmonary inflammation of allergic asthma mice by MicroRNA-144, -34a, and -34b\/c-modulated Nrf2 activation. J Agric Food Chem 64:151\u2013160. https:\/\/doi.org\/10.1021\/acs.jafc.5b04861","journal-title":"J Agric Food Chem"},{"key":"770_CR97","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1365-2222.2000.00093.x","volume":"30","author":"S Holgate","year":"2000","unstructured":"Holgate S (2000) The role of mast cells and basophils in inflammation. Clin Exp Allergy 30:28\u201332","journal-title":"Clin Exp Allergy"},{"key":"770_CR98","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2222.2008.02971.x","volume":"38","author":"ST Holgate","year":"2008","unstructured":"Holgate ST (2008) Pathogenesis of asthma. Clin Exp Allergy 38:872\u2013897","journal-title":"Clin Exp Allergy"},{"key":"770_CR99","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.0902287","volume":"184","author":"JC Horvat","year":"2010","unstructured":"Horvat JC et al (2010a) Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease. J Immunol 184:4159\u20134169","journal-title":"J Immunol"},{"issue":"617\u2013625","key":"770_CR100","first-page":"e616","volume":"125","author":"JC Horvat","year":"2010","unstructured":"Horvat JC et al (2010b) Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J Allergy Clin Immunol 125(617\u2013625):e616","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR101","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1067\/mai.2001.115626","volume":"107","author":"M Hoshino","year":"2001","unstructured":"Hoshino M, Nakamura Y, Hamid QA (2001a) Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 107:1034\u20131038","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR102","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1046\/j.1365-2222.2001.01071.x","volume":"31","author":"M Hoshino","year":"2001","unstructured":"Hoshino M, Takahashi M, Takai Y, Sim J, Aoike N (2001b) Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy 31:722\u2013730","journal-title":"Clin Exp Allergy"},{"key":"770_CR400","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/bcp.12589","volume":"80","author":"F Hua","year":"2015","unstructured":"Hua F, Ribbing J, Reinisch W, Cataldi F, Martin S (2015) A pharmacokinetic comparison of anrukinzumab, an anti\u2010IL\u201013 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients. British J Clin Pharmacol 80:101\u2013109","journal-title":"British J Clin Pharmacol"},{"key":"770_CR103","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1096\/fj.13-247247","volume":"28","author":"R Hu","year":"2014","unstructured":"Hu R et al (2014) MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway. FASEB J 28:2347\u20132357. https:\/\/doi.org\/10.1096\/fj.13-247247","journal-title":"FASEB J"},{"key":"770_CR104","first-page":"1061","volume":"122","author":"M Huang","year":"2009","unstructured":"Huang M, Liu X, Du Q, Yao X, Yin K-S (2009) Inhibitory effects of sunitinib on ovalbumin-induced chronic experimental asthma in mice. Chin Med J (Engl) 122:1061\u20131066","journal-title":"Chin Med J (Engl)"},{"key":"770_CR105","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaci.2015.05.044","volume":"136","author":"YJ Huang","year":"2015","unstructured":"Huang YJ, Nariya S, Harris JM, Lynch SV, Choy DF, Arron JR, Boushey H (2015) The airway microbiome in patients with severe asthma: associations with disease features and severity. J Allergy Clin Immunol 136:874\u2013884","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR106","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/ajrccm.156.3.9610033","volume":"156","author":"M Humbert","year":"1997","unstructured":"Humbert M, Corrigan CJ, Kimmitt P, Till SJ, BARRY KAY A, Durham SR, (1997) Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 156:704\u2013708","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR107","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/cea.12754","volume":"46","author":"X Huo","year":"2016","unstructured":"Huo X et al (2016) Decreased epithelial and plasma miR-181b-5p expression associates with airway eosinophilic inflammation in asthma. Clin Exp Allergy 46:1281\u20131290. https:\/\/doi.org\/10.1111\/cea.12754","journal-title":"Clin Exp Allergy"},{"key":"770_CR108","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1139\/bcb-2016-0010","volume":"94","author":"MH Hussein","year":"2016","unstructured":"Hussein MH, Toraih EA, Aly NM, Riad E, Fawzy MS (2016) A passenger strand variant in miR-196a2 contributes to asthma severity in children and adolescents: a preliminary study. Biochem Cell Biol 94:347\u2013357. https:\/\/doi.org\/10.1139\/bcb-2016-0010","journal-title":"Biochem Cell Biol"},{"key":"770_CR109","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1096\/fj.02-0691fje","volume":"17","author":"H Hutchings","year":"2003","unstructured":"Hutchings H, Ortega N, Plou\u00ebt J (2003) Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J 17:1520\u20131522","journal-title":"FASEB J"},{"key":"770_CR110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0014-2999(89)90212-4","volume":"163","author":"M Ichinose","year":"1989","unstructured":"Ichinose M, Barnes PJ (1989) Inhibitory histamine H3-receptors on cholinergic nerves in human airways. Eur J Pharmacol 163:383\u2013386","journal-title":"Eur J Pharmacol"},{"key":"770_CR111","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.4049\/jimmunol.99.6.1187","volume":"99","author":"K Ishizaka","year":"1967","unstructured":"Ishizaka K, Ishizaka T (1967) Identification of \u03b3E-antibodies as a carrier of reaginic activity. J Immunol 99:1187\u20131198","journal-title":"J Immunol"},{"key":"770_CR112","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1183\/09031936.01.00205801","volume":"18","author":"C Janson","year":"2001","unstructured":"Janson C et al (2001) The European Community Respiratory Health Survey: what are the main results so far? Eur Respir J 18:598\u2013611","journal-title":"Eur Respir J"},{"key":"770_CR113","first-page":"17","volume":"1","author":"SC Jayan","year":"2009","unstructured":"Jayan SC, Sandeep A, Rifash M, Mareema C, Shamseera S (2009) Design and in-vitro evaluation of gelatin microspheres of salbutamol sulphate. Hygeia 1:17\u201320","journal-title":"Hygeia"},{"key":"770_CR114","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2567.2007.02719.x","volume":"123","author":"GE Kaiko","year":"2008","unstructured":"Kaiko GE, Horvat JC, Beagley KW, Hansbro PM (2008) Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 123:326\u2013338","journal-title":"Immunology"},{"key":"770_CR115","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.4049\/jimmunol.180.4.2225","volume":"180","author":"GE Kaiko","year":"2008","unstructured":"Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, Foster PS, Beagley KW (2008) Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J Immunol 180:2225\u20132232","journal-title":"J Immunol"},{"key":"770_CR116","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/rccm.200401-123OC","volume":"169","author":"H Kanazawa","year":"2004","unstructured":"Kanazawa H, Nomura S, Yoshikawa J (2004) Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. Am J Respir Crit Care Med 169:1125\u20131130","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR117","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1378\/chest.06-2758","volume":"131","author":"H Kanazawa","year":"2007","unstructured":"Kanazawa H, Nomura S, Asai K (2007) Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients. Chest 131:1035\u20131041","journal-title":"Chest"},{"key":"770_CR118","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1345\/aph.1E651","volume":"40","author":"SB Karish","year":"2006","unstructured":"Karish SB, Gagnon JM (2006) The potential role of roflumilast: the new phosphodiesterase-4 inhibitor. Ann Pharmacother 40:1096\u20131104","journal-title":"Ann Pharmacother"},{"key":"770_CR119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2019.05.031","volume":"144","author":"R Kaur","year":"2019","unstructured":"Kaur R, Chupp G (2019) Phenotypes and endotypes of adult asthma: Moving toward precision medicine. J Allergy Clin Immunol 144:1\u201312","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/ijms20010213","volume":"20","author":"H Kawauchi","year":"2019","unstructured":"Kawauchi H, Yanai K, Wang D-Y, Itahashi K, Okubo K (2019) Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. Int J Mol Sci 20:213","journal-title":"Int J Mol Sci"},{"key":"770_CR121","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2018.08.028","volume":"837","author":"LJ Kay","year":"2018","unstructured":"Kay LJ, Suvarna SK, Peachell PT (2018) Histamine H4 receptor mediates chemotaxis of human lung mast cells. Eur J Pharmacol 837:38\u201344","journal-title":"Eur J Pharmacol"},{"key":"770_CR122","doi-asserted-by":"crossref","unstructured":"Khokhlovich E et al (2017) Late breaking abstract-the biological pathways underlying response to anti-IL-17A (AIN457; secukinumab) therapy differ across severe asthmatic patients. Eur Respir Soc 50:OA2897","DOI":"10.1183\/1393003.congress-2017.OA2897"},{"key":"770_CR123","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3904\/kjim.2017.066","volume":"32","author":"J-H Kim","year":"2017","unstructured":"Kim J-H (2017) Serum vascular endothelial growth factor as a marker of asthma exacerbation. Korean J Intern Med 32:258\u2013260","journal-title":"Korean J Intern Med"},{"key":"770_CR124","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/thoraxjnl-2014-206736","volume":"70","author":"RY Kim","year":"2015","unstructured":"Kim RY, Pinkerton JW, Gibson PG, Cooper MA, Horvat JC, Hansbro PM (2015) Inflammasomes in COPD and neutrophilic asthma. Thorax 70:1199\u20131201","journal-title":"Thorax"},{"key":"770_CR125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2016.04.038","volume":"139","author":"RY Kim","year":"2017","unstructured":"Kim RY et al (2017a) MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase\u2013mediated suppression of histone deacetylase 2. J Allergy Clin Immunol 139:519\u2013532","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1164\/rccm.201609-1830OC","volume":"196","author":"RY Kim","year":"2017","unstructured":"Kim RY et al (2017b) Role for NLRP3 inflammasome\u2013mediated, IL-1\u03b2\u2013dependent responses in severe, steroid-resistant asthma. Am J Respir Crit Care Med 196:283\u2013297","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR127","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1067\/mai.2003.104","volume":"111","author":"KS Konduri","year":"2003","unstructured":"Konduri KS, Nandedkar S, D\u00fczg\u00fcnes N, Suzara V, Artwohl J, Bunte R, Gangadharam PR (2003) Efficacy of liposomal budesonide in experimental asthma. J Allergy Clin Immunol 111:321\u2013327","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.rmed.2017.12.006","volume":"134","author":"P Korenblat","year":"2018","unstructured":"Korenblat P et al (2018) Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids. Respir Med 134:143\u2013149","journal-title":"Respir Med"},{"key":"770_CR129","first-page":"368","volume":"108","author":"TC Kotsimbos","year":"1996","unstructured":"Kotsimbos TC, Ernst P, Hamid QA (1996) Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc Assoc Am Physicians 108:368\u2013373","journal-title":"Proc Assoc Am Physicians"},{"key":"770_CR130","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1378\/chest.121.6.1782","volume":"121","author":"M Kraft","year":"2002","unstructured":"Kraft M, Cassell GH, Pak J, Martin RJ (2002) Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121:1782\u20131788","journal-title":"Chest"},{"key":"770_CR131","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/rccm.200601-007OC","volume":"174","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Diette GB, Rand CS, Bilderback AL, Merriman B, Hansel NN, Krishnan JA (2006) Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 174:633\u2013638","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR132","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","volume":"56","author":"ME Kuruvilla","year":"2019","unstructured":"Kuruvilla ME, Lee FE-H, Lee GB (2019) Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol 56:219\u2013233. https:\/\/doi.org\/10.1007\/s12016-018-8712-1","journal-title":"Clin Rev Allergy Immunol"},{"key":"770_CR133","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","volume":"371","author":"RG Langley","year":"2014","unstructured":"Langley RG et al (2014) Secukinumab in plaque psoriasis\u2014results of two phase 3 trials. N Engl J Med 371:326\u2013338","journal-title":"N Engl J Med"},{"key":"770_CR134","doi-asserted-by":"publisher","first-page":"377","DOI":"10.7150\/thno.16627","volume":"7","author":"GM Lanza","year":"2017","unstructured":"Lanza GM et al (2017) Anti-angiogenic nanotherapy inhibits airway remodeling and hyper-responsiveness of dust mite triggered asthma in the Brown Norway rat. Theranostics 7:377\u2013389. https:\/\/doi.org\/10.7150\/thno.16627","journal-title":"Theranostics"},{"key":"770_CR135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1067\/mai.2003.169","volume":"111","author":"M Larch\u00e9","year":"2003","unstructured":"Larch\u00e9 M, Robinson DS, Kay AB (2003) The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111:450\u2013463","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR136","doi-asserted-by":"crossref","first-page":"e13360","DOI":"10.1371\/journal.pone.0013360","volume":"5","author":"JY Lau","year":"2010","unstructured":"Lau JY et al (2010) Fibulin-1 is increased in asthma\u2013a novel mediator of airway remodeling? PLoS ONE 5:e13360","journal-title":"PLoS ONE"},{"key":"770_CR137","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","volume":"356","author":"MJ Leckie","year":"2000","unstructured":"Leckie MJ et al (2000) Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356:2144\u20132148","journal-title":"Lancet"},{"key":"770_CR138","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.4049\/jimmunol.168.7.3595","volume":"168","author":"YC Lee","year":"2002","unstructured":"Lee YC, Kwak Y-G, Song CH (2002) Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol 168:3595\u20133600","journal-title":"J Immunol"},{"key":"770_CR139","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaci.2005.11.008","volume":"117","author":"SY Lee","year":"2006","unstructured":"Lee SY et al (2006) Immunostimulatory DNA inhibits allergen-induced peribronchial angiogenesis in mice. J Allergy Clin Immunol 117:597\u2013603","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR140","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3904\/kjim.2017.207","volume":"33","author":"L Liang","year":"2018","unstructured":"Liang L, Hur J, Kang JY, Rhee CK, Kim YK, Lee SY (2018) Effect of the anti-IL-17 antibody on allergic inflammation in an obesity-related asthma model. Korean J Intern Med 33:1210","journal-title":"Korean J Intern Med"},{"key":"770_CR141","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11882-009-0066-6","volume":"9","author":"Y-CC Liu","year":"2009","unstructured":"Liu Y-CC, Post JC (2009) Biofilms in pediatric respiratory and related infections. Curr Allergy Asthma Rep 9:449\u2013455","journal-title":"Curr Allergy Asthma Rep"},{"key":"770_CR600","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11010-015-2519-7","volume":"409","author":"Y Liu","year":"2015","unstructured":"Liu Y, Sun X, Wu Y, Fang P, Shi H, Xu J, Li M (2015) Effects of miRNA-145 on airway smooth muscle cells function. Mol Cell Biochem 409:135\u2013143","journal-title":"Mol Cell Biochem"},{"key":"770_CR142","first-page":"e86380","volume":"1","author":"G Liu","year":"2016","unstructured":"Liu G et al (2016) Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases. J Clin Invest Insight 1:e86380","journal-title":"J Clin Invest Insight"},{"key":"770_CR143","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/path.4979","volume":"243","author":"G Liu","year":"2017","unstructured":"Liu G et al (2017) Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c. J Pathol 243:510\u2013523","journal-title":"J Pathol"},{"key":"770_CR144","doi-asserted-by":"crossref","first-page":"AB73","DOI":"10.1016\/j.jaci.2016.12.286","volume":"139","author":"M Londei","year":"2017","unstructured":"Londei M, Kenney B, Los G, Marino MH (2017) A Phase 1 study of ANB020, an anti-IL-33 monoclonal antibody in healthy volunteers. J Allergy Clin Immunol 139:AB73","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes8010001","volume":"8","author":"CM Long","year":"2016","unstructured":"Long CM, Lukomska E, Marshall NB, Nayak A, Anderson SE (2016) Potential Inhibitory Influence of miRNA 210 on Regulatory T Cells during Epicutaneous Chemical Sensitization. Genes 8:1\u20139","journal-title":"Genes"},{"key":"770_CR146","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2010.11.037","volume":"127","author":"J L\u00f6tvall","year":"2011","unstructured":"L\u00f6tvall J et al (2011) Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 127:355\u2013360","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR147","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000095677","volume":"74","author":"C Louw","year":"2007","unstructured":"Louw C, Williams Z, Venter L, Leichtl S, Schmid-Wirlitsch C, Bredenbr\u00f6ker D, Bardin P (2007) Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge. Respiration 74:411\u2013417","journal-title":"Respiration"},{"key":"770_CR148","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2015.12.009","volume":"81","author":"P Lovato","year":"2016","unstructured":"Lovato P, Norsgaard H, Tokura Y, R\u00f8pke MA (2016) Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell\u2013Th17 cell axis in psoriasis. J Dermatol Sci 81:153\u2013164","journal-title":"J Dermatol Sci"},{"key":"770_CR149","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12931-016-0330-y","volume":"17","author":"J Luo","year":"2016","unstructured":"Luo J, Wang K, Liu D, Liang B-M, Liu C-T (2016) Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis. Respir Res 17:18","journal-title":"Respir Res"},{"key":"770_CR150","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1093\/jn\/137.12.2730","volume":"137","author":"M Maret","year":"2007","unstructured":"Maret M et al (2007) Liposomal retinoic acids modulate asthma manifestations in mice. J Nutr 137:2730\u20132736","journal-title":"J Nutr"},{"issue":"Suppl","key":"770_CR151","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.alit.2016.04.018","volume":"65","author":"S Matsukura","year":"2016","unstructured":"Matsukura S et al (2016) Overexpression of microRNA-155 suppresses chemokine expression induced by Interleukin-13 in BEAS-2B human bronchial epithelial cells. Allergol Int 65(Suppl):S17-23. https:\/\/doi.org\/10.1016\/j.alit.2016.04.018","journal-title":"Allergol Int"},{"key":"770_CR152","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1164\/ajrccm.152.2.7633694","volume":"152","author":"PJ Mauser","year":"1995","unstructured":"Mauser PJ et al (1995) Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 152:467\u2013472","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR153","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","volume":"386","author":"IB McInnes","year":"2015","unstructured":"McInnes IB et al (2015) Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet 386:1137\u20131146","journal-title":"The Lancet"},{"key":"770_CR154","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4155\/fmc-2020-0091","volume":"12","author":"M Mehta","year":"2020","unstructured":"Mehta M, Chellappan DK, Wich PR, Hansbro NG, Hansbro PM, Dua K (2020a) miRNA nanotherapeutics: potential and challenges in respiratory disorders. Future Med Chem 12:987\u2013990","journal-title":"Future Med Chem"},{"key":"770_CR155","doi-asserted-by":"crossref","unstructured":"Mehta M et al (2020b) Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update. Inflammopharmacology 28(4):1\u201323","DOI":"10.1007\/s10787-020-00698-3"},{"key":"770_CR156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-012-0317-9","volume":"13","author":"N Meyer","year":"2013","unstructured":"Meyer N, Akdis CA (2013) Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways. Curr Allergy Asthma Rep 13:1\u20139","journal-title":"Curr Allergy Asthma Rep"},{"key":"770_CR157","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361:888\u2013898","journal-title":"N Engl J Med"},{"key":"770_CR158","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.chest.2016.10.042","volume":"151","author":"PD Mitchell","year":"2017","unstructured":"Mitchell PD, O\u2019byrne PM, (2017) Epithelial-derived cytokines in asthma. Chest 151:1338\u20131344","journal-title":"Chest"},{"key":"770_CR159","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4049\/jimmunol.1301538","volume":"192","author":"N Mizutani","year":"2014","unstructured":"Mizutani N, Nabe T, Yoshino S (2014) IL-17A promotes the exacerbation of IL-33\u2013induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice. J Immunol 192:1372\u20131384","journal-title":"J Immunol"},{"key":"770_CR160","first-page":"925","volume":"18","author":"T M\u00fcller","year":"2006","unstructured":"M\u00fcller T et al (2006) Functional characterization of histamine receptor subtypes in a human bronchial epithelial cell line. Int J Mol Med 18:925\u2013931","journal-title":"Int J Mol Med"},{"key":"770_CR161","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/1535370216685006","volume":"242","author":"HA Murad","year":"2017","unstructured":"Murad HA, Habib HS, Rafeeq MM, Sulaiman MI, Abdulrahman AS, Khabaz MN (2017) Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice. Exp Biol Med 242:516\u2013526","journal-title":"Exp Biol Med"},{"key":"770_CR162","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.biopha.2018.08.123","volume":"107","author":"A Nadeem","year":"2018","unstructured":"Nadeem A, Al-Harbi NO, Alfardan AS, Ahmad SF, AlAsmari AF, Al-Harbi MM (2018) IL-17A-induced neutrophilic airway inflammation is mediated by oxidant-antioxidant imbalance and inflammatory cytokines in mice. Biomed Pharmacother 107:1196\u20131204","journal-title":"Biomed Pharmacother"},{"key":"770_CR163","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","volume":"360","author":"P Nair","year":"2009","unstructured":"Nair P et al (2009) Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 360:985\u2013993","journal-title":"N Engl J Med"},{"key":"770_CR164","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","volume":"17","author":"S Nakae","year":"2002","unstructured":"Nakae S et al (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375\u2013387","journal-title":"Immunity"},{"key":"770_CR165","unstructured":"Narayanan V, Baglole C, Eidelman DH, Hussain S, Martin JG, Hamid Q, Panariti A (2016) Increased vascularity of the bronchial mucosa in patients with severe asthma and the role Of IL-17a in angiogenesis and vascular remodeling. In: Novel mechanisms of allergy and airway inflammation. American Thoracic Society, 193:A6680"},{"key":"770_CR166","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijpharm.2013.11.023","volume":"461","author":"M Nasr","year":"2014","unstructured":"Nasr M, Najlah M, D\u2019Emanuele A, Elhissi A (2014) PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization. Int J Pharm 461:242\u2013250","journal-title":"Int J Pharm"},{"key":"770_CR167","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.200211-1268OC","volume":"168","author":"A Niimi","year":"2003","unstructured":"Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M (2003) Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med 168:983\u2013988","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR168","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2016.10.016","volume":"169","author":"J Nixon","year":"2017","unstructured":"Nixon J, Newbold P, Mustelin T, Anderson GP, Kolbeck R (2017) Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation. Pharmacol Ther 169:57\u201377","journal-title":"Pharmacol Ther"},{"key":"770_CR169","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1172\/JCI200315932","volume":"111","author":"N Novak","year":"2003","unstructured":"Novak N, Tepel C, Koch S, Brix K (2003) Evidence for a differential expression of the Fc\u03b5RI\u03b3 chain in dendritic cells of atopic and nonatopic donors. J Clin Invest 111:1047\u20131056","journal-title":"J Clin Invest"},{"key":"770_CR170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.alit.2016.06.004","volume":"66","author":"H Odajima","year":"2017","unstructured":"Odajima H et al (2017) Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma. Allergol Int 66:106\u2013115","journal-title":"Allergol Int"},{"key":"770_CR171","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.alit.2020.04.001","volume":"69","author":"K Okubo","year":"2020","unstructured":"Okubo K et al (2020) Japanese guidelines for allergic rhinitis 2020. Allergol Int 69:331\u2013345","journal-title":"Allergol Int"},{"key":"770_CR172","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4314\/tjpr.v7i2.14684","volume":"7","author":"L Pachuau","year":"2008","unstructured":"Pachuau L, Sarkar S, Mazumder B (2008) Formulation and evaluation of matrix microspheres for simultaneous delivery of salbutamol sulphate and theophylline. Trop J Pharm Res 7:995\u20131002","journal-title":"Trop J Pharm Res"},{"key":"770_CR173","doi-asserted-by":"crossref","unstructured":"Page C, O\u2019Shaughnessy B, Barnes P (2016) Pathogenesis of COPD and Asthma. In: Page C, Barnes P (eds) Pharmacology and Therapeutics of Asthma and COPD. Handbook of Experimental Pharmacology, vol 237. Springer, Cham","DOI":"10.1007\/978-3-319-52175-6"},{"key":"770_CR174","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.4103\/0975-7406.94160","volume":"4","author":"R Panchal","year":"2012","unstructured":"Panchal R, Patel H, Patel V, Joshi P, Parikh A (2012) Formulation and evalution of montelukast sodium-chitosan based spray dried microspheres for pulmonary drug delivery. J Pharm Bioallied Sci 4:S110\u2013S111","journal-title":"J Pharm Bioallied Sci"},{"key":"770_CR175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2213-2600(18)30184-X","volume":"6","author":"RA Panettieri","year":"2018","unstructured":"Panettieri RA et al (2018) Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials. Lancet Respir Med 6:511\u2013525","journal-title":"Lancet Respir Med"},{"key":"770_CR176","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.4103\/0975-7406.94139","volume":"4","author":"DD Patel","year":"2012","unstructured":"Patel DD, Patel VN, Thakkar TV, Gandhi RT (2012) Preparation and evaluation of Levosalbutamol sulphate chitosan microsphere for the treatment of asthma. J Pharm Bioallied Sci 4:S46\u2013S47","journal-title":"J Pharm Bioallied Sci"},{"key":"770_CR177","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","volume":"380","author":"ID Pavord","year":"2012","unstructured":"Pavord ID et al (2012) Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 380:651\u2013659","journal-title":"Lancet"},{"key":"770_CR178","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1753465808100431","volume":"2","author":"G Pelaia","year":"2008","unstructured":"Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R (2008) Review: Omalizumab in the treatment of severe asthma: efficacy and current problems. Ther Adv Respir Dis 2:409\u2013421","journal-title":"Ther Adv Respir Dis"},{"key":"770_CR179","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nrd3792","volume":"11","author":"G Pelaia","year":"2012","unstructured":"Pelaia G, Vatrella A, Maselli R (2012) The potential of biologics for the treatment of asthma. Nat Rev Drug Discov 11:958\u2013972","journal-title":"Nat Rev Drug Discov"},{"key":"770_CR180","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1166\/jbn.2015.2163","volume":"11","author":"X Peng","year":"2015","unstructured":"Peng X et al (2015) Targeting mast cells and basophils with anti-Fc\u03b5RI\u03b1 fab-conjugated celastrol-loaded micelles suppresses allergic inflammation. J Biomed Nanotechnol 11:2286\u20132299","journal-title":"J Biomed Nanotechnol"},{"key":"770_CR181","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1183\/09031936.00223411","volume":"41","author":"E Piper","year":"2013","unstructured":"Piper E et al (2013) A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. Eur Respir J 41:330\u2013338","journal-title":"Eur Respir J"},{"key":"770_CR182","doi-asserted-by":"crossref","first-page":"e0144810","DOI":"10.1371\/journal.pone.0144810","volume":"10","author":"MW Plank","year":"2015","unstructured":"Plank MW, Maltby S, Tay HL, Stewart J, Eyers F, Hansbro PM, Foster PS (2015) MicroRNA expression is altered in an ovalbumin-induced asthma model and targeting miR-155 with antagomirs reveals cellular specificity. PLoS ONE 10:e0144810","journal-title":"PLoS ONE"},{"key":"770_CR183","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1183\/09031936.00073312","volume":"41","author":"R Polosa","year":"2013","unstructured":"Polosa R, Thomson NC (2013) Smoking and asthma: dangerous liaisons. Eur Respir J 41:716\u2013726. https:\/\/doi.org\/10.1183\/09031936.00073312","journal-title":"Eur Respir J"},{"key":"770_CR184","doi-asserted-by":"crossref","unstructured":"Prasher P et al (2020) Plants derived therapeutic strategies targeting chronic respiratory diseases: chemical and immunological perspective. Chem Biol Interact 325:109125","DOI":"10.1016\/j.cbi.2020.109125"},{"key":"770_CR185","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.151.5.2623","volume":"151","author":"LG Presta","year":"1993","unstructured":"Presta LG, Lahr S, Shields R, Porter J, Gorman C, Fendly B, Jardieu P (1993) Humanization of an antibody directed against IgE. J Immunol 151:2623\u20132632","journal-title":"J Immunol"},{"key":"770_CR186","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4103\/0250-474X.43000","volume":"70","author":"J Qureshi","year":"2008","unstructured":"Qureshi J, Amir M, Ahuja A, Baboota S, Ali J (2008) Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma. Indian J Pharm Sci 70:351\u2013356","journal-title":"Indian J Pharm Sci"},{"key":"770_CR187","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF et al (2018) Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med 378:2475\u20132485. https:\/\/doi.org\/10.1056\/NEJMoa1804093","journal-title":"N Engl J Med"},{"key":"770_CR188","doi-asserted-by":"crossref","first-page":"11872","DOI":"10.1021\/acsnano.5b04215","volume":"9","author":"SS Raesch","year":"2015","unstructured":"Raesch SS et al (2015) Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. ACS Nano 9:11872\u201311885","journal-title":"ACS Nano"},{"key":"770_CR189","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mai.2000.104575","volume":"105","author":"S Romagnani","year":"2000","unstructured":"Romagnani S (2000) The role of lymphocytes in allergic disease. J Allergy Clin Immunol 105:399\u2013408","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR190","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/cea.13388","volume":"49","author":"M Salomonsson","year":"2019","unstructured":"Salomonsson M, Malinovschi A, Kalm-Stephens P, Dahlin JS, Janson C, Alving K, Hallgren J (2019) Circulating mast cell progenitors correlate with reduced lung function in allergic asthma. Clin Exp Allergy 49:874\u2013882","journal-title":"Clin Exp Allergy"},{"key":"770_CR191","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/thorax.56.12.902","volume":"56","author":"G Salvato","year":"2001","unstructured":"Salvato G (2001) Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 56:902\u2013906","journal-title":"Thorax"},{"key":"770_CR192","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016015926","volume":"33","author":"S Saraf","year":"2016","unstructured":"Saraf S, Jain A, Hurkat P, Jain SK (2016) Topotecan liposomes: a visit from a molecular to a therapeutic platform. Crit Rev Ther Drug Carrier Syst 33:401\u2013432","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"770_CR193","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/cea.12220","volume":"44","author":"H Scheerens","year":"2014","unstructured":"Scheerens H et al (2014) The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge. Clin Exp Allergy 44:38\u201346","journal-title":"Clin Exp Allergy"},{"key":"770_CR194","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/eji.200323809","volume":"33","author":"A Schipf","year":"2003","unstructured":"Schipf A, Heilmann A, Boue L, Mossmann H, Brocker T, R\u00f6cken M (2003) Th2 cells shape the differentiation of developing T cell responses during interactions with dendritic cells in vivo. Eur J Immunol 33:1697\u20131706","journal-title":"Eur J Immunol"},{"key":"770_CR195","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1365-2222.1995.tb03249.x","volume":"25","author":"A Shah","year":"1995","unstructured":"Shah A, Church M, Holgate S (1995) Tumour necrosis factor alpha: a potential mediator of asthma. Clin Exp Allergy (Print) 25:1038\u20131044","journal-title":"Clin Exp Allergy (Print)"},{"key":"770_CR196","doi-asserted-by":"crossref","first-page":"16251","DOI":"10.1039\/C5NR04726A","volume":"7","author":"S Shahabi","year":"2015","unstructured":"Shahabi S, Treccani L, Dringen R, Rezwan K (2015) Utilizing the protein corona around silica nanoparticles for dual drug loading and release. Nanoscale 7:16251\u201316265","journal-title":"Nanoscale"},{"key":"770_CR197","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1152\/japplphysiol.00001.2012","volume":"113","author":"A Sharma","year":"2012","unstructured":"Sharma A, Kumar M, Ahmad T, Mabalirajan U, Aich J, Agrawal A, Ghosh B (2012) Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model. J Appl Physiol 113:459\u2013464. https:\/\/doi.org\/10.1152\/japplphysiol.00001.2012","journal-title":"J Appl Physiol"},{"key":"770_CR198","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/13543784.2014.866092","volume":"23","author":"MD Shastri","year":"2014","unstructured":"Shastri MD, Peterson GM, Stewart N, Sohal SS, Patel RP (2014) Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality? Expert Opin Investig Drugs 23:357\u2013373","journal-title":"Expert Opin Investig Drugs"},{"key":"770_CR199","doi-asserted-by":"crossref","first-page":"e0118798","DOI":"10.1371\/journal.pone.0118798","volume":"10","author":"MD Shastri","year":"2015","unstructured":"Shastri MD et al (2015a) Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics. PLoS ONE 10:e0118798","journal-title":"PLoS ONE"},{"key":"770_CR200","doi-asserted-by":"crossref","first-page":"e0128803","DOI":"10.1371\/journal.pone.0128803","volume":"10","author":"MD Shastri","year":"2015","unstructured":"Shastri MD et al (2015b) Non-anticoagulant fractions of enoxaparin suppress inflammatory cytokine release from peripheral blood mononuclear cells of allergic asthmatic individuals. PLoS ONE 10:e0128803","journal-title":"PLoS ONE"},{"key":"770_CR201","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000237010","volume":"107","author":"R Shields","year":"1995","unstructured":"Shields R et al (1995) Inhibition of allergic reactions with antibodies to IgE. Int Arch Allergy Immunol 107:308\u2013312","journal-title":"Int Arch Allergy Immunol"},{"key":"770_CR202","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.coph.2019.06.003","volume":"46","author":"SD Shukla","year":"2019","unstructured":"Shukla SD et al (2019) Microbiome-focused asthma management strategies. Curr Opin Pharmacol 46:143\u2013149","journal-title":"Curr Opin Pharmacol"},{"key":"770_CR203","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/ATVBAHA.108.172015","volume":"28","author":"R Silva","year":"2008","unstructured":"Silva R, D\u2019Amico G, Hodivala-Dilke KM, Reynolds LE (2008) Integrins The keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol 28:1703\u20131713","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"770_CR204","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","volume":"11","author":"JL Simpson","year":"2006","unstructured":"Simpson JL, Scott R, Boyle MJ, Gibson PG (2006) Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 11:54\u201361","journal-title":"Respirology"},{"key":"770_CR205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-10-3","volume":"10","author":"D Singh","year":"2010","unstructured":"Singh D, Kane B, Molfino NA, Faggioni R, Roskos L, Woodcock A (2010) A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma. BMC Pulm Med 10:1\u20138","journal-title":"BMC Pulm Med"},{"key":"770_CR206","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1081-1206(10)62264-8","volume":"87","author":"JD Spahn","year":"2001","unstructured":"Spahn JD, Fost DA, Covar R, Martin RJ, Brown EE, Szefler SJ, Leung DY (2001) Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study. Ann Allergy, Asthma Immunol 87:501\u2013505","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"770_CR207","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mi.2012.99","volume":"6","author":"M Starkey","year":"2013","unstructured":"Starkey M et al (2013a) Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease. Mucosal Immunol 6:569\u2013579","journal-title":"Mucosal Immunol"},{"key":"770_CR208","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.coph.2013.03.005","volume":"13","author":"MR Starkey","year":"2013","unstructured":"Starkey MR et al (2013b) Murine models of infectious exacerbations of airway inflammation. Curr Opin Pharmacol 13:337\u2013344","journal-title":"Curr Opin Pharmacol"},{"key":"770_CR209","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41385-018-0130-4","volume":"12","author":"MR Starkey","year":"2019","unstructured":"Starkey MR, McKenzie ANJ, Belz GT, Hansbro PM (2019) Pulmonary group 2 innate lymphoid cells: surprises and challenges. Mucosal Immunol 12:299\u2013311","journal-title":"Mucosal Immunol"},{"key":"770_CR210","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/ajrccm.164.8.2010002","volume":"164","author":"RG Stirling","year":"2001","unstructured":"Stirling RG, Van Rensen EL, Barnes PJ, Fan Chung K (2001) Interleukin-5 induces CD34+ eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med 164:1403\u20131409","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR211","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jaci.2005.08.052","volume":"116","author":"Y Suzaki","year":"2005","unstructured":"Suzaki Y et al (2005) A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model. J Allergy Clin Immunol 116:1220\u20131227","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR212","unstructured":"Szefler S, Kattan M, Ortiz B, Trzaskoma B, Haselkorn T, Iqbal A, Busse W (2018) Greater treatment benefit with omalizumab in children with increased asthma severity: exploratory analyses from the preventative omalizumab or step-up therapy for fall exacerbations (PROSE) Study. In: Pediatric severe asthma and phenotyping. American Thoracic Society 201:A1157"},{"key":"770_CR213","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2016.03.031","volume":"505","author":"K Tahara","year":"2016","unstructured":"Tahara K et al (2016) Pulmonary liposomal formulations encapsulated procaterol hydrochloride by a remote loading method achieve sustained release and extended pharmacological effects. Int J Pharm 505:139\u2013146","journal-title":"Int J Pharm"},{"key":"770_CR214","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1165\/rcmb.2003-0305OC","volume":"31","author":"H Tanaka","year":"2004","unstructured":"Tanaka H et al (2004) Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. Am J Respir Cell Mol Biol 31:62\u201368","journal-title":"Am J Respir Cell Mol Biol"},{"key":"770_CR215","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/scd.2015.0339","volume":"25","author":"GN Tang","year":"2016","unstructured":"Tang GN et al (2016) MicroRNAs involved in asthma after mesenchymal stem cells treatment. Stem Cells Dev 25:883\u2013896. https:\/\/doi.org\/10.1089\/scd.2015.0339","journal-title":"Stem Cells Dev"},{"key":"770_CR216","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3389\/fimmu.2018.01873","volume":"9","author":"EB Thangam","year":"2018","unstructured":"Thangam EB et al (2018) The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the hunt for new therapeutic targets. Front Immunol 9:1873","journal-title":"Front Immunol"},{"key":"770_CR217","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.4049\/jimmunol.166.9.5792","volume":"166","author":"A Tomkinson","year":"2001","unstructured":"Tomkinson A et al (2001) A murine IL-4 receptor antagonist that inhibits IL-4-and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol 166:5792\u20135800","journal-title":"J Immunol"},{"key":"770_CR218","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1152\/ajplegacy.1975.229.4.1008","volume":"229","author":"A Tucker","year":"1975","unstructured":"Tucker A, Weir EK, Reeves J, Grover R (1975) Histamine H1-and H2-receptors in pulmonary and systemic vasculature of the dog. Am J Physiol-Leg Content 229:1008\u20131013","journal-title":"Am J Physiol-Leg Content"},{"key":"770_CR500","first-page":"255","volume":"8","author":"RM Tuder","year":"2008","unstructured":"Tuder RM, Yun JH (2008) Vascular endothelial growth factor of the lung: friend or foe. Curr pin Psychopharmacol 8:255\u2013260","journal-title":"Curr pin Psychopharmacol"},{"key":"770_CR219","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1365-2222.2010.03544.x","volume":"40","author":"A Vazquez-Tello","year":"2010","unstructured":"Vazquez-Tello A, Semlali A, Chakir J, Martin J, Leung D, Eidelman D, Hamid Q (2010) Induction of glucocorticoid receptor-\u03b2 expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy 40:1312\u20131322","journal-title":"Clin Exp Allergy"},{"key":"770_CR220","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s10875-012-9828-3","volume":"33","author":"A Vazquez-Tello","year":"2013","unstructured":"Vazquez-Tello A, Halwani R, Hamid Q, Al-Muhsen S (2013) Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells. J Clin Immunol 33:466\u2013478","journal-title":"J Clin Immunol"},{"key":"770_CR221","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200801-086OC","volume":"178","author":"H Wakashin","year":"2008","unstructured":"Wakashin H et al (2008) IL-23 and Th17 cells enhance Th2-cell\u2013mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 178:1023\u20131032","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR222","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3892\/etm.2015.2702","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y, Mao G, Lv Y, Huang Q, Wang G (2015) MicroRNA-181b stimulates inflammation via the nuclear factor-kappaB signaling pathway in vitro. Exp Ther Med 10:1584\u20131590. https:\/\/doi.org\/10.3892\/etm.2015.2702","journal-title":"Exp Ther Med"},{"key":"770_CR223","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13287-016-0456-3","volume":"8","author":"SY Wang","year":"2017","unstructured":"Wang SY et al (2017) The lncRNAs involved in mouse airway allergic inflammation following induced pluripotent stem cell-mesenchymal stem cell treatment. Stem Cell Res Ther 8:2. https:\/\/doi.org\/10.1186\/s13287-016-0456-3","journal-title":"Stem Cell Res Ther"},{"key":"770_CR224","unstructured":"Wark P, Nichol K, Dorahy D, Collison A, Mattes J (2018) The effect of treatment with omalizumab on anti-viral responses in adults with severe allergic asthma. In: Immunotherapy in lung disease. American Thoracic Society. 197:A6166"},{"key":"770_CR225","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel SE (2012) Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 18:716\u2013725","journal-title":"Nat Med"},{"key":"770_CR226","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pupt.2013.07.003","volume":"26","author":"SE Wenzel","year":"2013","unstructured":"Wenzel SE (2013) Complex phenotypes in asthma: current definitions. Pulm Pharmacol Ther 26:710\u2013715","journal-title":"Pulm Pharmacol Ther"},{"key":"770_CR227","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","volume":"160","author":"SE Wenzel","year":"1999","unstructured":"Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW (1999) Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160:1001\u20131008","journal-title":"Am J Respir Crit Care Med"},{"key":"770_CR228","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","volume":"388","author":"S Wenzel","year":"2016","unstructured":"Wenzel S et al (2016) Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet 388:31\u201344","journal-title":"Lancet"},{"key":"770_CR229","unstructured":"Wisnivesky JP et al (2017) Impact of exacerbations on lung function in patients with asthma. In: Improving asthma management: research at the Forefront. American Thoracic Society, 195:A2632"},{"key":"770_CR230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1710-1492-4-1-1","volume":"4","author":"P Xepapadaki","year":"2008","unstructured":"Xepapadaki P, Koutsoumpari I, Papaevagelou V, Karagianni C, Papadopoulos NG (2008) Atypical bacteria and macrolides in asthma. Allergy, Asthma Clini Immunol 4:1\u20136","journal-title":"Allergy, Asthma Clini Immunol"},{"key":"770_CR231","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.4049\/jimmunol.1502081","volume":"196","author":"Y Xiang","year":"2016","unstructured":"Xiang Y, Eyers F, Herbert C, Tay HL, Foster PS, Yang M (2016) MicroRNA-487b is a negative regulator of macrophage activation by targeting IL-33 production. J Immunol 196:3421\u20133428","journal-title":"J Immunol"},{"key":"770_CR232","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/ijms20071733","volume":"20","author":"K Yamauchi","year":"2019","unstructured":"Yamauchi K, Ogasawara M (2019) The role of histamine in the pathophysiology of asthma and the clinical efficacy of antihistamines in asthma therapy. Int J Mol Sci 20:1733","journal-title":"Int J Mol Sci"},{"key":"770_CR233","doi-asserted-by":"crossref","first-page":"L342","DOI":"10.1152\/ajplung.1994.267.3.L342","volume":"267","author":"K Yamauchi","year":"1994","unstructured":"Yamauchi K et al (1994) Structure and function of human histamine N-methyltransferase: critical enzyme in histamine metabolism in airway. Am J Physiol-Lung Cell Mol Physiol 267:L342\u2013L349","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"770_CR234","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.0711357","volume":"91","author":"M Yang","year":"2012","unstructured":"Yang M, Kumar RK, Hansbro PM, Foster PS (2012) Emerging roles of pulmonary macrophages in driving the development of severe asthma. J Leukoc Biol 91:557\u2013569","journal-title":"J Leukoc Biol"},{"key":"770_CR235","first-page":"1","volume":"5","author":"JY Yhee","year":"2016","unstructured":"Yhee JY, Im J, Nho RS (2016) Advanced therapeutic strategies for chronic lung disease using nanoparticle-based drug delivery. J Clin Med 5:1\u201313","journal-title":"J Clin Med"},{"key":"770_CR236","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jamp.2015.1273","volume":"30","author":"A Yildiz-Pekoz","year":"2017","unstructured":"Yildiz-Pekoz A, Ozsoy Y (2017) Inhaled heparin: therapeutic efficacy and recent formulations. J Aerosol Med Pulm Drug Deliv 30:143\u2013156","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"770_CR237","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/127170","volume":"2013","author":"SY Yoo","year":"2013","unstructured":"Yoo SY, Kwon SM (2013) Angiogenesis and its therapeutic opportunities. Mediators Inflamm 2013:1\u201311","journal-title":"Mediators Inflamm"},{"key":"770_CR238","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.anai.2012.12.015","volume":"110","author":"H Yuksel","year":"2013","unstructured":"Yuksel H et al (2013) Role of vascular endothelial growth factor antagonism on airway remodeling in asthma. Ann Allergy, Asthma Immunol 110:150\u2013155","journal-title":"Ann Allergy, Asthma Immunol"},{"key":"770_CR239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-11-132","volume":"11","author":"A Zanini","year":"2010","unstructured":"Zanini A, Chetta A, Imperatori AS, Spanevello A, Olivieri D (2010) The role of the bronchial microvasculature in the airway remodelling in asthma and COPD. Respir Res 11:1\u201311","journal-title":"Respir Res"},{"key":"770_CR240","first-page":"3409","volume":"8","author":"XY Zhang","year":"2016","unstructured":"Zhang XY et al (2016) LncRNAs BCYRN1 promoted the proliferation and migration of rat airway smooth muscle cells in asthma via upregulating the expression of transient receptor potential 1. Am J Transl Res 8:3409\u20133418","journal-title":"Am J Transl Res"},{"key":"770_CR241","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/02770909709068189","volume":"34","author":"C-Y Zhou","year":"1997","unstructured":"Zhou C-Y, Crocker IC, Koenig G, Romero FA, Townley RG (1997) Anti-interleukin-4 inhibits immunoglobulin E production in a murine model of atopic asthma. J Asthma 34:195\u2013201","journal-title":"J Asthma"},{"key":"770_CR242","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17101773","volume":"17","author":"H Zhou","year":"2016","unstructured":"Zhou H, Li J, Gao P, Wang Q, Zhang J (2016) miR-155: a novel target in allergic asthma. Int J Mol Sci 17:1\u201311. https:\/\/doi.org\/10.3390\/ijms17101773","journal-title":"Int J Mol Sci"},{"key":"770_CR243","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jaci.2006.04.060","volume":"118","author":"J-P Zock","year":"2006","unstructured":"Zock J-P et al (2006) Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II. J Allergy Clin Immunol 118:682\u2013690","journal-title":"J Allergy Clin Immunol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00770-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-020-00770-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-020-00770-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T14:44:50Z","timestamp":1697035490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-020-00770-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":250,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["770"],"URL":"https:\/\/doi.org\/10.1007\/s10787-020-00770-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}